Filing Details

Accession Number:
0001126234-21-000113
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-13 16:32:42
Reporting Period:
2021-08-11
Accepted Time:
2021-08-13 16:32:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1126234 Lumos Pharma Inc. (LUMO) Pharmaceutical Preparations (2834) 421491350
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1709258 Aaron Schuchart 4200 Marathon Blvd
Suite 200
Austin TX 78756
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-11 300 $7.35 1,337 No 4 P Direct
Common Stock Acquisiton 2021-08-12 1,700 $7.42 3,037 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Includes 695 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments with the next installment occurring on February 1, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
  2. Includes 109 shares acquired under the Lumos Pharma, Inc. 2010 Employee Stock Purchase Plan on June 30, 2021.